Mesenchymal Cell Replacement Corrects Thymic Hypoplasia in Murine Models of 22q11.2 Deletion Syndrome

    September 2022 in “ Journal of Clinical Investigation
    Pratibha Bhalla, Qiumei Du, Ashwani Kumar, Chao Xing, Angela Moses, Igor Dozmorov, Christian Wysocki, Ondine Cleaver, Timothy J. Pirolli, M. Louise Markert, M. Teresa de la Morena, Antonio Baldini, Nicolai S. C. van Oers
    From the encyclopedia
    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Studysummary In this study, mouse models of 22q11.2 deletion syndrome showed that growth issues in small embryonic thymuses were linked to mesenchymal cells, which could be corrected by substituting with normal mesenchyme.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results